Chemotherapy Regimen clinical trials

A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias

This study looks at a new drug, SNDX-5613, combined with standard chemotherapy for a type of blood cancer called Acute Myeloid Leukemia (AML). It aims to see how safe and effective this new combination is for people whose AML has specific genetic changes.